Ellipsis Health has pioneered an artificial intelligence-powered, speech-based vital sign to quantify and manage depression and anxiety symptoms at scale. With depression and anxiety symptoms impacting one third of Americans and costing the global society over $1 trillion dollars each year, Ellipsis' integrated behavioral health solution helps healthcare providers and payors reliably identify and evaluate high-risk patient populations. Machine-learning algorithms assess patient speech through cloud-based deep learning models and generate a science-based assessment of anxiety and depression symptoms for clinical decision support.